Hartford Investment Management Co. Cuts Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Hartford Investment Management Co. reduced its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.0% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 11,694 shares of the company’s stock after selling 745 shares during the quarter. Hartford Investment Management Co.’s holdings in HCA Healthcare were worth $4,753,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Terra Nova Asset Management LLC lifted its holdings in shares of HCA Healthcare by 0.3% in the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after buying an additional 26 shares during the period. Massmutual Trust Co. FSB ADV raised its holdings in HCA Healthcare by 7.4% during the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after purchasing an additional 29 shares during the last quarter. Waldron Private Wealth LLC raised its holdings in HCA Healthcare by 1.8% during the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after purchasing an additional 29 shares during the last quarter. Brookstone Capital Management raised its holdings in HCA Healthcare by 0.7% during the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after purchasing an additional 30 shares during the last quarter. Finally, UMB Bank n.a. raised its holdings in HCA Healthcare by 2.4% during the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after purchasing an additional 30 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,345 shares of company stock valued at $5,747,945 over the last quarter. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the subject of several research reports. Royal Bank of Canada lifted their price objective on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Barclays boosted their price target on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft boosted their price target on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a report on Friday, June 28th. KeyCorp started coverage on HCA Healthcare in a report on Friday, October 11th. They issued an “overweight” rating and a $475.00 price target for the company. Finally, StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and four have issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $367.15.

HCA Healthcare Price Performance

HCA stock opened at $410.03 on Thursday. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $417.14. The stock has a 50-day moving average price of $394.72 and a two-hundred day moving average price of $352.30. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company has a market cap of $107.39 billion, a PE ratio of 20.44, a price-to-earnings-growth ratio of 1.44 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same quarter in the prior year, the business earned $4.29 earnings per share. The company’s revenue was up 10.3% compared to the same quarter last year. As a group, research analysts predict that HCA Healthcare, Inc. will post 22.51 EPS for the current year.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.